Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek

Wednesday, September 5, 2007 General News
Email Print This Page Comment
WALTHAM, Mass., Sept. 5 Thermo Fisher ScientificInc. (NYSE: TMO), the world leader in serving science, has acquired theinstrument sales business of Davis Inotek Instruments, LLC. The acquiredbusiness will be branded Davis Instruments and excludes its relatedcalibration services. Davis Instruments is a leading provider of test,measurement and process control instruments, serving customers in a wide rangeof industries through its extensive catalog and e-commerce sales channels. Theinstrument sales business had revenues of approximately $30 million in 2006.

Davis Instruments will become part of Thermo Fisher's Cole-Parmer customerchannel, a specialty catalog brand that provides technical instruments,equipment and supplies to industrial, pharmaceutical, academic and governmentcustomers around the world.

"Our Cole-Parmer channel is a well-known resource for the specialtyinstruments and consumables that our customers need for their scientificresearch or industrial process applications," commented Marijn E. Dekkers,president and chief executive officer of Thermo Fisher Scientific. "Theaddition of Davis Instruments is a perfect complement to the Cole-Parmerchannel, and will strengthen our ability to meet our customers' needs througha range of convenient purchasing options."

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is the world leader in servingscience, enabling our customers to make the world healthier, cleaner andsafer. With an annual revenue rate of more than $9 billion, we employ 30,000people and serve over 350,000 customers within pharmaceutical and biotechcompanies, hospitals and clinical diagnostic labs, universities, researchinstitutions and government agencies, as well as environmental and industrialprocess control settings. Serving customers through two premier brands, ThermoScientific and Fisher Scientific, we help solve analytical challenges fromroutine testing to complex research and discovery. Thermo Scientific offerscustomers a complete range of high-end analytical instruments as well aslaboratory equipment, software, services, consumables and reagents to enableintegrated laboratory workflow solutions. Fisher Scientific provides acomplete portfolio of laboratory equipment, chemicals, supplies and servicesused in healthcare, scientific research, safety and education. Together, weoffer the most convenient purchasing options to customers and continuouslyadvance our technologies to accelerate the pace of scientific discovery,enhance value for customers and fuel growth for shareholders and employeesalike. Visit http://www.thermofisher.com .

The following constitutes a "Safe Harbor" statement under the PrivateSecurities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Importantfactors that could cause actual results to differ materially from thoseindicated by such forward-looking statements are set forth in the Company'sQuarterly Report on Form 10-Q for the quarter ended June 30, 2007, under thecaption "Risk Factors," which is on file with the Securities and ExchangeCommission and available in the "Investors" section of our Website under theheading "SEC Filings." We also may make forward-looking statements about thebenefits of the merger of Thermo Electron and Fisher Scientific, includingstatements about future financial and operating results, the new company'splans, objectives, expectations and intentions and other statements that arenot historical facts. Important factors that could cause actual results todiffer materially from those indicated by forward-looking statements includerisks and uncertainties relating to: the risk that the businesses will not beintegrated successfully; the risk that the cost savings and any othersynergies from the transaction may not be fully realized or may take longer torealize than e


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook